Agios Pharmaceuticals Inc (AGIO)

55.13 -0.55  -0.99% NASDAQ Apr 21, 14:33 USD
View Full Chart
Price Chart
View All AGIO News


View All Events


Date Type Description
04/30/2020 08:00 EDT Earnings Calls Q1 2020 Earnings Call
04/30/2020 00:00 Earnings Results Q1 2020 Earnings Results
05/28/2020 09:00 EDT Agm 2019 Annual General Meeting
07/30/2020 08:00 EDT Earnings Calls Q2 2020 Earnings Call
07/30/2020 00:00 Earnings Results Q2 2020 Earnings Results
11/05/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/05/2020 08:00 EST Earnings Calls Q3 2020 Earnings Call
02/25/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/25/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
04/29/2021 00:00 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Apr. 29, 2021
  • Last Earnings Release: Feb. 25, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F000013KMW ST Healthcare Innovations 7 F RE 3.56%
BBP Virtus LifeSci Biotech Products ETF 3.51%
FBT First Trust NYSE Arca Biotech ETF 3.40%
SBIO ALPS Medical Breakthroughs ETF 2.92%
FIJYX Fidelity Advisor® Biotechnology Z 2.86%
GSANX Goldman Sachs Small Cap Growth R 1.24%
IBBJ Defiance Nasdaq Junior Biotechnology ETF 1.11%
XBI SPDR® S&P Biotech ETF 0.77%
LABU Direxion Daily S&P Biotech Bull 3X ETF 0.59%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.